Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

12 févr. 2024 15h44 HE | Source: Monteverde & Associates PC

ALERT: The M&A Class Action Firm Launches Investigation of the Merger – WISH, IONM, CBAY, FANG

NEW YORK, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders...
09 mars 2020 19h51 HE | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CymaBay Therapeutics (CBAY) Investors Who Have Suffered Losses to Contact its Attorneys: Investigation Into Possible Securities Fraud Ongoing

SAN FRANCISCO, March 09, 2020 (GLOBE NEWSWIRE) -- Hagens Berman urges investors in CymaBay Therapeutics, Inc. (NASDAQ: CBAY) who have suffered significant losses to submit their losses now. The...
03 mars 2020 12h27 HE | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CymaBay Therapeutics (CBAY) Investors Who Have Suffered Losses to Contact its Attorneys: Firm Investigating Possible Securities Fraud

SAN FRANCISCO, March 03, 2020 (GLOBE NEWSWIRE) -- Hagens Berman urges investors in CymaBay Therapeutics, Inc. (NASDAQ: CBAY) who have suffered significant losses to submit their losses now. The...